maní

Condiciones de salud que maní puede ayudar a apoyar.

• HipocondríaCientífico

  Peanuts contain vitamin E, resveratrol, flavonoids, and phenolic acids that collectively raise total antioxidant capacity. A randomised crossover trial in hypercholesterolaemic men found 77 g/day peanuts significantly increased total antioxidant capacity. Peanut skin polyphenols show neuroprotective antioxidant effects in cell studies.

• AcnéCientífico

  Clinical trials show peanuts and peanut butter increase satiety hormones (GLP-1, PYY, CCK) and reduce desire to eat. A randomised crossover trial in obese women found peanut butter consumption lowered postprandial glucose and enhanced gut satiety hormone secretion. Pre-meal peanut intake has been shown to moderate appetite in energy-restricted weight loss diets.

• Síndrome de Inmunodeficiencia AdquiridaCientífico

  Peanuts contain L-arginine (NO precursor), MUFA, resveratrol, and phytosterols that collectively support arterial endothelial function and reduce arterial stiffness. Clinical RCTs and meta-analyses confirm peanuts improve cholesterol ratios and triglycerides linked to atherosclerosis risk. An ongoing RCT in prediabetes includes arterial stiffness as a primary endpoint.

• HipotensiónCientífico

  The evidence for peanuts and blood pressure is mixed but some trials suggest a modest benefit, particularly in hypertensive individuals. A 6-month peanut-enriched weight-loss RCT assessed blood pressure as a secondary endpoint. The ARISTOTLE RCT and a meta-analysis of peanut trials did not find consistent significant blood pressure reductions at the pooled level.

• Fatiga SuprarrenalCientífico

  Peanuts have a low glycaemic index and several trials show they moderate postprandial glucose responses. A meta-analysis of 40 RCTs found nut/peanut consumption significantly reduced HOMA-IR and fasting insulin. Peanut butter added to a high-carbohydrate breakfast attenuated blood glucose excursions in obese women.

• Válvula IleocecalCientífico

  Multiple RCTs and meta-analyses confirm peanuts lower total cholesterol, LDL-C, and the LDL:HDL ratio while increasing HDL-C. Plant sterols in peanuts block intestinal cholesterol absorption. A crossover RCT in 54 hypercholesterolaemic men found significant reductions in TC/HDL and LDL/HDL ratios with ~77 g/day peanuts.

• ApendicitisCientífico

  Peanuts contain polyphenols including resveratrol and flavonoids with documented anti-inflammatory activity. Clinical and epidemiological evidence from nut-consumption studies associate regular intake with reductions in inflammatory markers. Peanuts' unsaturated fats and bioactive compounds contribute to reduction of oxidative stress and inflammation.

• IncontinenciaCientífico

  A 16-week RCT found daily peanut consumption improved brain vascular function and verbal memory in older adults. Niacin from foods (peanuts are a primary source) was prospectively associated with slower cognitive decline in ~4,000 adults over 65. Peanut skin polyphenols show neuroprotective effects in preclinical models.

• InfecciónCientífico

  The Nurses' Health Study (n=80,718, 20-year follow-up) found women consuming one serving of peanuts almost daily had a 20% reduced risk of cholecystectomy. Consuming peanut butter five or more times weekly was associated with a 15% reduced risk. Fibre, unsaturated fats, phytosterols, and magnesium in peanuts are proposed mechanisms.

• Leche materna (secar)Científico

  Peanut fibre acts as a prebiotic, and peanut-derived resveratrol has been shown to modulate gut microbiota composition in preclinical models by enriching Lactobacillus and Bifidobacterium. An ongoing RCT (ClinicalTrials.gov NCT06867198) is directly studying peanuts' effects on gut microbiota. Peanut polyphenols also support gut barrier integrity.

• BronquitisCientífico

  Epidemiological data show frequent nut/peanut consumers have lower all-cause mortality. Peanuts' resveratrol activates SIRT1 longevity pathways. Daily peanut consumption improved brain vascular function and memory in older adults in a 16-week RCT. Dietary niacin and vitamin E from peanuts are prospectively associated with reduced cognitive decline.

• Moretones (prevención)Científico

  Multiple RCTs and observational data show that regular peanut consumption does not promote weight gain and can support weight management. An RCT incorporating 70 g/day peanuts in an energy-restricted diet achieved ~7.5% body weight loss comparable to a low-fat diet. Epidemiological data confirm nut consumers tend to weigh less than non-consumers.

• JuanetesCientífico

  Peanuts carry an FDA qualified health claim for heart disease risk reduction at 1.5 oz/day. Multiple RCTs and meta-analyses demonstrate beneficial effects on LDL cholesterol, TC:HDL ratio, and triglycerides. A randomised crossover trial in hypercholesterolaemic men showed 77 g/day peanuts significantly improved LDL/HDL and total/HDL ratios and raised HDL-C.

• Olor de piesCientífico

  A systematic review and meta-analysis of 40 RCTs found peanut and tree nut consumption significantly decreased HOMA-IR and fasting insulin, indicating improved insulin sensitivity. Individual trials corroborate the finding in diabetic and at-risk populations. Fibre, MUFA, magnesium, and arginine in peanuts are plausible mechanistic mediators.

• EscalofríosCientífico

  A 16-week RCT found daily unsalted skin-roasted peanut consumption improved verbal memory and brain vascular function in older adults. Peanuts are rich in niacin, vitamin E, and resveratrol, all linked to cognitive protection. Niacin from food intake has been prospectively associated with slower cognitive decline in large observational studies.

• GingivitisCientífico

  Regular nut consumption, including peanuts, is associated with favourable effects on multiple components of metabolic syndrome including blood pressure, visceral adiposity, lipids, and insulin resistance. Peanut-derived resveratrol has been studied in metabolic syndrome contexts. Clinical and epidemiological data support peanuts as part of dietary management of MetS.

• Colon (espástico)Científico

  Peanuts are one of the richest dietary sources of L-arginine, the obligate substrate for endothelial nitric oxide synthase (eNOS). L-arginine supplementation in clinical studies increases NO production, improves flow-mediated dilation, and reduces arterial stiffness. This mechanistic pathway underlies peanuts' known cardiovascular and vascular benefits.

• ConvulsionesCientífico

  Peanuts are rich in folate (up to 60% RDA per 100 g), providing a key nutrient for preventing neural tube defects and supporting fetal brain development. Adequate folate intake during pregnancy is robustly linked to reduced neural tube defect risk, recognised by the WHO. Peanuts also provide iron, magnesium, and B vitamins relevant in pregnancy.

• DebilidadCientífico

  Multiple RCTs and a meta-analysis of 9 studies demonstrate that peanut consumption reduces blood triglyceride levels. The effect is greater in healthy subjects than in those at high metabolic risk. Reductions are most consistent with regular peanuts and peanut butter rather than high-oleic variants.

Sistemas corporales que maní puede ayudar a apoyar.

• No hay sistemas corporales disponibles.